Voxiom Products
Premium research peptides with 99%+ purity
ALL PRODUCTS
RETATRUTIDE 30MG (1 VIAL): The Triple Agonist That’s Outperforming Tirzepatide
Reta is an investigational drug, still in clinical trials, that acts as a triple agonist targeting three different receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.
Supplied strictly for in-vitro laboratory research and analytical reference. Not for human or veterinary use. Not a food additive, cosmetic or household chemical. Not intended to diagnose, treat, cure or prevent any disease.
Purity
Verified by independent labs
USA Made
Synthesized in domestic facilities